Detect and protect against AMD
Age Related Macular Degeneration (AMD) is the leading cause of blindness in older people in the developed world.
It affects 30% of those aged over 65, and is set to increase.
AMD is associated with a low level of retinal carotenoids, which are collectively known as the macular pigment (MP). MP is a blue light filter and has antioxidant and anti-inflammatory properties.
Dr Ian Murray and colleagues at The University of Manchester have developed a new instrument, the Macular Pigment Screener (MPS), which allows patients to have their MP levels routinely tested in ophthalmic clinics.
This means that, for the first time, patients can be advised if their MP is low and, if so, how to increase it. This will help to avoid the development or progression of AMD.
Over 750 instruments have been sold worldwide, with more than one million patients in the United States alone estimated to be benefiting from MP monitoring.
"... currently the quickest, most affordable, and most clinically relevant device in the world. The technology will revolutionise the practice of eye care."Dr Stuart Richer / Chief of Optometry, Captain James A Lovell Federal Health Facility, North Chicago, USA